10-Q: Acadia Healthcare Reports Solid Revenue Growth in Second Quarter 2024, Expands Bed Capacity

Acadia Healthcare Company, Inc. announced an 8.8% revenue increase for the first half of 2024, driven by growth in patient days and revenue per patient day, alongside strategic bed expansion.

Summary

• Acadia Healthcare reported a revenue of $796 million for the three months ended June 30, 2024, an 8.8% increase compared to the same period in 2023.
• For the six months ended June 30, 2024, revenue reached $1.564 billion, a 9.0% increase year-over-year.
• The company's same-facility revenue grew by 8.3% in the second quarter and 8.8% in the first half of 2024, driven by a 2.6% and 2.4% increase in patient days, respectively, and a 5.6% and 6.2% increase in revenue per patient day, respectively.
• Acadia added 184 beds in the first half of 2024, including 64 beds in existing facilities and 120 beds through the opening of two new facilities.
• The company expects to add approximately 1,200 total beds and open up to fourteen Comprehensive Treatment Centers (CTCs) by the end of 2024, excluding acquisitions.
• Net income attributable to Acadia Healthcare Company, Inc. was $78.5 million for the three months ended June 30, 2024, and $154.9 million for the six months ended June 30, 2024.
• The company's adjusted EBITDA margin remained flat for the three months ended June 30, 2024, but increased by 60 basis points for the six months ended June 30, 2024.
• The company incurred a $1 million non-cash property impairment charge related to closed facilities in the second quarter of 2024.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with strong revenue growth, bed expansion, and improved operational efficiency. While there are some challenges, the overall tone is optimistic and indicates a healthy trajectory for the company.

Positives

• Acadia experienced strong revenue growth, with an 8.8% increase in the second quarter and a 9.0% increase in the first half of 2024.
• The company's same-facility revenue growth indicates solid organic performance.
• The increase in patient days and revenue per patient day demonstrates strong demand for Acadia's services.
• The company is actively expanding its bed capacity, adding 184 beds in the first half of 2024 and planning for 1,200 more by year-end.
• The planned opening of up to fourteen new CTCs suggests a strategic focus on expanding service offerings.
• The adjusted EBITDA margin improvement for the first half of 2024 indicates improved operational efficiency.

Negatives

• The company incurred a $1 million non-cash property impairment charge related to closed facilities.
• Cash used in operating activities was $150.1 million for the six months ended June 30, 2024, compared to cash provided by operating activities of $208.2 million for the same period in 2023.
• Interest expense increased to $29.2 million for the three months ended June 30, 2024, and $56.4 million for the six months ended June 30, 2024, primarily due to increased borrowings under the Credit Facility.

Risks

• The company faces competition for staffing, labor shortages, and higher turnover rates, which could impact labor costs and profitability.
• Inflation and interest rate volatility could affect the company's financial performance.
• The company is subject to various legal proceedings, governmental investigations, and regulatory actions.
• The company's indebtedness and ability to meet debt obligations pose a risk.
• The company's reliance on government and third-party payors for revenue makes it vulnerable to changes in payment policies.
• The company's acquisition and joint venture strategies expose it to operational, financial, legal, and regulatory risks.
• The company's ability to recruit and retain qualified personnel is critical to its success.
• The company is exposed to risks related to cyber-security incidents and information system failures.
• The company's performance is subject to fluctuations in operating results and other factors that could affect the price of its securities.

Future Outlook

Acadia expects to add approximately 1,200 total beds and open up to fourteen CTCs by the end of 2024, excluding acquisitions. The company is focused on becoming the indispensable behavioral healthcare provider for high-acuity and complex needs patients.

Management Comments

• Management believes that we are positioned as a leading platform in a highly fragmented industry under the direction of an experienced management team that has significant industry expertise.
• Management expects to take advantage of several strategies that are more accessible as a result of our increased size and geographic scale, including continuing a national marketing strategy to attract new patients and referral sources, increasing our volume of out-of-state referrals, providing a broader range of services to new and existing patients and clients and selectively pursuing opportunities to expand our facility and bed count in the U.S. through acquisitions, wholly-owned de novo facilities, joint ventures and bed additions in existing facilities.

Industry Context

Acadia operates in the behavioral healthcare industry, which is experiencing growing demand. The company's expansion plans and focus on high-acuity patients align with industry trends. The company is a leading publicly traded pure-play provider of behavioral healthcare services in the U.S.

Comparison to Industry Standards

• Acadia's revenue growth of 8.8% and 9.0% for the three and six months ended June 30, 2024, respectively, is strong compared to the overall healthcare sector, which has seen moderate growth.
• The company's focus on expanding bed capacity and opening new facilities is consistent with the industry's need to address the growing demand for behavioral healthcare services.
• Acadia's adjusted EBITDA margin improvement of 60 basis points for the six months ended June 30, 2024, indicates better operational efficiency compared to some peers.
• Compared to Universal Health Services (UHS), which also operates behavioral health facilities, Acadia's growth rate is competitive, though UHS has a broader range of healthcare services.
• Acadia's focus on a pure-play behavioral health model differentiates it from companies like HCA Healthcare, which has a more diversified portfolio of healthcare services.

Management Changes

Legal Proceedings

• The company is subject to various claims, lawsuits, governmental investigations, and regulatory actions.
• The company settled the Desert Hills Litigation for $400 million in January 2024.
• The company is involved in ongoing securities litigation and derivative actions.
• The company has reached a tentative agreement to resolve a government investigation with an anticipated financial impact of $19.9 million.

Stakeholder Impact

• Shareholders will benefit from the company's revenue growth and strategic expansion.
• Employees may experience changes due to the company's focus on managing labor costs and staffing.
• Patients will have increased access to behavioral healthcare services due to the company's bed expansion and new facility openings.
• The company's financial performance will impact its relationships with creditors and suppliers.

Next Steps

• The company plans to add approximately 1,200 total beds by the end of 2024.
• The company plans to open up to fourteen new CTCs by the end of 2024.
• The company will continue to monitor the implications of potential tax legislation in each of its jurisdictions.
• The company will continue to evaluate the impact of recently issued accounting standards.

Key Dates

Keywords

behavioral healthcare, psychiatric facilities, substance abuse treatment, revenue growth, bed expansion, EBITDA, acquisitions, joint ventures, healthcare services, mental health